Objective: This paper aims to study the mapping of high-risk oncogenic Human Papilloma Virus in clients who received voluntary cervical cancer screening in five health regions of Burkina Faso. Patients and Methods: This was a multicenter and cross-sectional study with a descriptive aim which took place over a period of 25 months from July 1, 2021 to July 30, 2023. Results: Our study population consisted of 8512 clients who had taken the HPV DNA test in the health regions named Center, Center-West, Center-East, Plateau Central and Cascades in Burkina Faso. The average age of the clients was 38.03 ± 9.69 years. The overall prevalence of HR-HPV was 22.99%. The “Other HPV” serotypes were the most frequent in a proportion of 54.27%, followed by serotypes 16 and 18 respectively in 14.46% and 13.95% of cases. The prevalence of HR-HPV was 42.75% among HIV + clients. The serotypes of the “Other HPV” group (HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) were the most common among clients with a precancerous cervical lesion in 57.54% of cases. Conclusion: The health regions of Center, Center-East, Center-West, Plateau Central and Cascades in Burkina Faso have a high prevalence of HR-HPV. The “Other HPV” serotypes were the most dominant. A further study to identify by isolating the prevalence of the different serotypes of the “Other HPV” group in these five health regions of Burkina Faso is essential to be able to choose the most appropriate type of HPV vaccine.
References
[1]
OMS (2022) Cancer du col de l’utérus: Principaux faits. https://www.who.int/fr/news-room/fact-sheets/detail/cervical-cancer
[2]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: ACancerJournalforClinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[3]
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Piñeros, M., Znaor, A., et al. (2021) Cancer Statistics for the Year 2020: An Overview. InternationalJournalofCancer, 149, 778-789. https://doi.org/10.1002/ijc.33588
Lei, J., Ploner, A., Elfström, K.M., Wang, J., Roth, A., Fang, F., et al. (2020) HPV Vaccination and the Risk of Invasive Cervical Cancer. NewEnglandJournalofMedicine, 383, 1340-1348. https://doi.org/10.1056/nejmoa1917338
[6]
Tedros, A.G. (2020) Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. World Health Organization, 1-56.
[7]
Zohoncon, T.M., Wendkuuni, F., Djigma, W.F., Ouattara, A.K., Traoré, I.M.A., Ouédraogo, A.R., et al. (2020) Mapping of Fourteen High-Risk Human Papillomavirus Genotypes by Molecular Detection in Sexually Active Women in the West African Sub-Region. International Journal of Genetics and Molecular Biology, 12, 11-21.
[8]
Horo, A., Aka, E. and Koné, M. (2022) Ivoirian Molecular Profile of High-Risk Human Papillomavirus: Preliminary Study of 250 Cases in a Single Center in Abidjan. International Journal of Research and Reports in Gynaecology, 5, 31-40.
[9]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in France. Summary Report 22 October 2021, 53-66.
[10]
Yan, X., Huang, Y., Zhang, M., Hu, X., Li, K. and Jing, M. (2020) Prevalence of Human Papillomavirus Infection and Type Distribution among Uyghur Females in Xinjiang, Northwest China. OncologyLetters, 20, Article No. 25. https://doi.org/10.3892/ol.2020.11886
[11]
Faye, B., Diallo, F., Sarr, H., Sembene, P.M. and Dieye, A. (2020) Molecular Genotyping of Human Papilloma Virus (HPV) in Women with Normal Endo-Cervical Cytology in Senegal. ScholarsAcademicJournalofBiosciences, 8, 23-29. https://doi.org/10.36347/sajb.2020.v08i02.002
[12]
Hatzipanagiotou, M., Holzinger, D., Millogo, F., Pawlita, M. and Wacker, J. (2018) Human Papillomaviruses in Western Africa: Prevalences and Risk Factors in Burkina Faso. Archives of Gynecology and Obstetrics, 298, 789-796.
[13]
Ouedraogo, R.A., Zohoncon, T.M., Ouattara, A.K. and Simpore, J. (2020) Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso. JournalofAppliedBiosciences, 150, 15499-15509. https://doi.org/10.35759/jabs.150.10
[14]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Germany. Summary Report 22 October 2021, 53-66.
[15]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Morocco. Summary Report 22 October 2021, 54-67.
[16]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in South Africa. Summary Report 22 October 2021, 54-67.
[17]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Thailand. Summary Report 22 October 2021, 53-67.
[18]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in United States of Amicrica. Summary Report 22 October 2021, 64-82.
[19]
Kabuga, A., Nejati, A., Arero, A., Jalilvand, S., Mokhtari-Azad, T., Sighaldeh, S., et al. (2020) Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis. AsianPacificJournalofCancerPrevention, 21, 2837-2846. https://doi.org/10.31557/apjcp.2020.21.10.2837
[20]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., et al. (2021) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Guinea. Summary Report 22 October 2021, 54-67.
[21]
Ouédraogo, C., Ilboudo, R., Traoré, E.M.A., Zohoncon, T.M., Ouédraogo, A.R., Traoré, I.M.A., et al. (2020) Prevalence and Characterization of High-Risk Human Papillomavirus Genotypes among a Group of Sex Workers in Ouagadougou, Burkina Faso. EC Gynaecology, 9, 1-9.
[22]
Nyasenu, Y.T., Gbeasor-Komlanvi, F.A., Ehlan, A., Issa, S.A., Dossim, S., Kolou, M., et al. (2019) Prevalence and Distribution of Human Papillomavirus (HPV) Genotypes among HIV Infected Women in Lomé, Togo. PLOSONE, 14, e0212516. https://doi.org/10.1371/journal.pone.0212516
[23]
Nworie, O., Onu, E., Ogbu, O., Ejikeugwu, C., Agah, M., Ekuma, U., et al. (2020) Seroprevalence and Co-Infection of Human Papillomavirus (HPV) Genotypes among HIV Positives. AmericanJournalofInfectiousDiseases, 16, 27-35. https://doi.org/10.3844/ajidsp.2020.27.35
[24]
Ouedraogo, R.A., Zohoncon, T.M., Traore, I.M.A., Ouattara, A.K., Guigma, S.P., Djigma, F.W., et al. (2020) Genotypic Distribution of Human Oncogenic Papillomaviruses in Sexually Active Women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins Regions. BiomolecularConcepts, 11, 125-136. https://doi.org/10.1515/bmc-2020-0011
[25]
Dufit, V., Adenis, A., Douine, M., Najioullah, F., Kilie, O., Molinie, V., et al. (2016) Epidémiologie de l’infection à papillomavirus humains chez les femmes âgées de 20 à 65 ans résidant dans des communes isolées de Guyane française: Adapter l’action au territoire. Bulletin épidémiologiquehebdomadaire, 34, 588-597.
